Method for decreasing sebum production
AssigneeMedicis Pharmaceutical Corporation
InventorsCatherine R. Kostlan, Raj Neil Raheja, Meera Tugnait, Kimberly Wade
Life of this patent
Estimating the term…
Abstract
The present invention is directed to the topical application of the malonamide ACAT inhibitors described by Formula I. Other aspects of the invention are directed to topical formulations of these diamides, their use to treat sebaceous gland disorders and their use to alleviate oily skin.
Claims16
A method for alleviating oily skin comprising administering to a patient in need thereof, an effective amount of a compound of the formula:
- in which R1 and R2 are each independently C1-6 alkyl;
- X is CH2;
- R3 is C1-6 alkyl or pyridyl;
- p is 1;
- R4 is selected from the group consisting of C1-6 alkyl, C1-6 alkoxy, and SR7;
- R7 is C1-6 alkyl;
- or a pharmaceutically acceptable salt thereof.
A method for decreasing sebum secretion comprising administering to a patient in need thereof, an effective amount of a compound of the formula:
- in which R1 and R2 are each independently C1-6 alkyl;
- X is CH2;
- R3 is C1-6 aiki or pyridyl;
- p is 1;
- R4 is selected from the group consisting of C1-6 alkyl, C1-6 alkoxy, and SR7;
- R7 is C1-6 alkyl;
- or a pharmaceutically acceptable salt thereof.
A method for decreasing sebum secretion comprising administering to a patient in need thereof, an effective amount of a compound of the formula:
- in which R3 is C1-6 alkyl or pyridyl;
- R4 is selected from the group consisting of C1-6 alkyl, C1-6 alkoxy, and SR7;
- R7 is C1-6 alkyl;
- or a pharmaceutically acceptable salt thereof.
A method for treating acne comprising administering to a patient in need thereof, an effective amount of a compound of the formula:
- in which R1 and R2 are each independently C1-6 alkyl;
- X is CH2;
- R3 is C1-6 alkyl or pyridyl;
- p is 1;
- R4 is selected from the group consisting of C1-6 alkyl, C1-6 alkoxy, and SR7;
- R7 is C1-6 alkyl;
- or a pharmaceutically acceptable salt thereof.
An article of manufacture comprising a compound of the formula
- in which R1 and R2 are each independently C1-6 alkyl;
- X is CH2;
- R3 is C1-6 alkyl or pyridyl;
- p is 1;
- R4 is selected from the group consisting of C1-6 alkyl, C1-6 alkoxy, and SR7;
- R7 is C1-6 alkyl;
- or a pharmaceutically acceptable salt thereof, packaged for retail distribution, which advises a consumer how to utilize the compound to alleviate a condition selected from the group consisting of acne, oily skin, and seborrheic dermatitis.
A method for alleviating oily skin comprising administering to a patient in need thereof, an effective amount of a compound of the formula:
- in which R3 is C1-6 alkyl or pyridyl;
- R4 is selected from the group consisting of C1-6 alkyl, C1-6 alkoxy, and SR7;
- R7 is C1-6 alkyl;
- or a pharmaceutically acceptable salt thereof.
A method for treating acne comprising administering to a patient in need thereof an effective amount of a compound of the formula:
- in which R3 is C1-6 alkyl or pyridyi;
- R4 is selected from the group consisting of C1-6 alkyl, C1-6 alkoxy, and SR7;
- R7 is C1-6 alkyl;
- or a pharmaceutically acceptable salt thereof.
A method for treating seborrheic dermatitis comprising administering to a patient in need thereof an effective amount of a compound of the formula:
- in which R1 and R2 are each independently C1-6 alkyl;
- X is CH2;
- R3 is C1-6 alkyl or pyridyl;
- p is 1;
- R4 is selected from the group consisting of C1-6 alkyl, C1-6 alkoxy, and SR7;
- R7 is C1-6 alkyl;
- or a pharmaceutically acceptable salt thereof.
A method for treating seborrheic dermatitis comprising administering to a patient in need thereof, an effective amount of a compound of the formula:
- in which R3 is C1-6 alkyl or pyridyl;
- R4 is selected from the group consisting of C1-6 alkyl, C1-6 alkoxy, and SR7;
- R7 is C1-6 alkyl;
- or a pharmaceutically acceptable salt thereof.
An article of manufacture comprision a compound of the formula
- in which R3 is C1-6 alkyl or pyridyl;
- R4 is selected from the group consisting of C1-6 alkyl, C1-6 alkoxy, and SR7;
- R7 is C1-6 alkyl;
- or a pharmaceutically acceptable salt thereof, packaged for retail distribution, which advises a consumer how to utilize the compound to alleviate a condition selected from the group consistion of acne, oily skin, and seborrheic dermatits.
Dependencies are inferred from the claim text.